CHRISTINA FIGUEROA: Open Payments
NPI 1841972817 · AURORA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$973 in 49 payments from 12 companies in 2025. Trend: 2023 $18 · 2024 $873 · 2025 $973
Food & beverage: $973
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $287 |
| Novo Nordisk Inc | 12 | $275 |
| Lilly USA, LLC | 8 | $138 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| ABBVIE INC. | 2 | $48 |
| Exact Sciences Corporation | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| Phathom Pharmaceuticals, Inc. | 2 | $20 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Orexo US, Inc. | 1 | $17 |
Products named: AIRSUPRA, Ozempic, MOUNJARO, Rybelsus, FARXIGA, CAPLYTA, VRAYLAR, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
